BRIEF-Alexion receives positive CHMP opinion for Soliris in the EU
* Alexion receives positive CHMP opinion for Soliris (eculizumab) for the treatment of patients with refractory Generalized Myasthenia Gravis (GMG) in the European Union
(Corrects headline to Federal Reserve instead of NY Fed, corrects paragraph 1 to Tuesday instead of Monday)
WASHINGTON May 30 The Federal Reserve on Tuesday said it had fined Deutsche Bank AG $41 million for failing to ensure its systems would detect money laundering regulations and it said the lender agreed to increase its controls.
The New York Fed found that the German bank had faulty systems to detect suspicious transactions between 2011 and 2015, the central bank said in its filing. (Reporting By Patrick Rucker)
* Ultragenyx pharmaceutical inc - based on agreement, submission of burosumab bla is planned for second half of 2017
* Perficient Inc - acquisition is expected to be accretive to adjusted earnings per share immediately